Global stock markets are expected to gain this week as a potential COVID-19 treatment that raises hopes for economic recovery following mounting cases and hospitalizations in multiple United States (US) states and several countries. Gilead Sciences Inc said that its antiviral remdesivir improved clinical recovery in COVID-19 patients, and reduced the risk of death by 62%. At the same time, BioNTech announced its vaccine treatment could be ready for approval by December.

To subscribe please click here